Fda Committee S News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda committee s. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Committee S Today - Breaking & Trending Today

MSNBC MTP Daily October 26, 2021 17:43:00

We are back. joining me now for more on we expect this fda vote later today on whether they will approve the pfizer vaccine. joining me to discuss this is an infectious disease physician and director of the boston center for emerging infectious diseases policy and research. doctor, i want to start with the decision pfizer made on the doses for kids 5 to 11 versus other countries. they ve done it in some places just one dose. all of it has to do with the side effect here perhaps of heart inflammation. is there a what is the best practice that you ve seen so far on this? yeah, chuck, he think the fda committee s job is exactly what you said which is really making plain the case that benefits far ....

Boston Center , Emerging Infectious Diseases , Heart Inflammation , Side Effect , Chuck Todd , Fda Committee S ,

MSNBC MTP Daily October 26, 2021 17:45:00

91% effective against symptomatic disease. i think the lower dose the fda scientists also feel is likely to lead to fewer cases of the rare complication and so the two dose i think is probably the right way to go. the safety data contained within that trial data showed no incidents. just so rare it may not have been picked up. i think that the committee is likely to approve this and if they do what you ll likely see is the fda potentially takes that recommendation and next week the cdc s advisory committee will adapt it of course to who can get it and where. is there any thought that this, is it that there should be by a physical component here instead of just age? some 11-year-old are huge. some 13-year-old are small. yeah, and there is a range, right? in this trial as well i think you ve seen sort of, yes. in some ways it is an artificial ....

Fda Committee S , Cdcs Advisory Committee ,

MSNBC MTP Daily October 26, 2021 17:39:00

Age 5 through 11. in just a few hours the advisory committee will vote on the data specifically whether the benefits of vaccinating children outweigh the potential risk. this is the first key meeting in a regulatory process that could finish up as soon as the end of next week and means 28 million children may be able to roll up their sleeves within days. pfizer s involves two shots three weeks apart and each contains one-third of the dose used on adult. a clinical trial of more than 2,000 children voed vaccination 90.7% effective at preventing symptomatic covid-19 and fda suggested it far outweighs the risk of covid-19. getting covid-19 is much worse. we ll have more after the break. this. is the planning effect. this is how it feels to have a dedicated fidelity advisor ....

Fda Committee S , 28 Million , Covid 19 , 90 7 , Planning Effect ,